Envestnet Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
73,259
+25,120
| +52% | +$666K | ﹤0.01% | 2845 |
|
|
2025
Q1 | $1.16M | Buy |
48,139
+6,294
| +15% | +$152K | ﹤0.01% | 3107 |
|
|
2024
Q4 | $1.68M | Sell |
41,845
-9,382
| -18% | -$378K | ﹤0.01% | 2812 |
|
|
2024
Q3 | $3.24M | Buy |
51,227
+30,873
| +152% | +$1.95M | ﹤0.01% | 2370 |
|
|
2024
Q2 | $1.08M | Buy |
20,354
+675
| +3% | +$35.8K | ﹤0.01% | 2989 |
|
|
2024
Q1 | $1.61M | Buy |
+19,679
| New | +$1.61M | ﹤0.01% | 2707 |
|
|
2023
Q3 | – | Sell |
-16,626
| Closed | -$270K | – | 4169 |
|
|
2023
Q2 | $270K | Sell |
16,626
-948
| -5% | -$15.4K | ﹤0.01% | 3542 |
|
|
2023
Q1 | $293K | Buy |
17,574
+2,283
| +15% | +$38K | ﹤0.01% | 3451 |
|
|
2022
Q4 | $144K | Sell |
15,291
-1,091
| -7% | -$10.3K | ﹤0.01% | 3742 |
|
|
2022
Q3 | $45K | Sell |
16,382
-1,974
| -11% | -$5.42K | ﹤0.01% | 3815 |
|
|
2022
Q2 | $53K | Buy |
+18,356
| New | +$53K | ﹤0.01% | 3814 |
|
|
2021
Q4 | – | Sell |
-31,050
| Closed | -$195K | – | 3953 |
|
|
2021
Q3 | $195K | Buy |
31,050
+1,417
| +5% | +$8.9K | ﹤0.01% | 3510 |
|
|
2021
Q2 | $178K | Buy |
29,633
+677
| +2% | +$4.07K | ﹤0.01% | 3511 |
|
|
2021
Q1 | $183K | Buy |
28,956
+8,659
| +43% | +$54.7K | ﹤0.01% | 3363 |
|
|
2020
Q4 | $114K | Sell |
20,297
-8,033
| -28% | -$45.1K | ﹤0.01% | 3195 |
|
|
2020
Q3 | $165K | Sell |
28,330
-3,492
| -11% | -$20.3K | ﹤0.01% | 2956 |
|
|
2020
Q2 | $229K | Sell |
31,822
-7,826
| -20% | -$56.3K | ﹤0.01% | 2818 |
|
|
2020
Q1 | $186K | Sell |
39,648
-446
| -1% | -$2.09K | ﹤0.01% | 2751 |
|
|
2019
Q4 | $322K | Buy |
40,094
+1,885
| +5% | +$15.1K | ﹤0.01% | 2697 |
|
|
2019
Q3 | $263K | Sell |
38,209
-478
| -1% | -$3.29K | ﹤0.01% | 2732 |
|
|
2019
Q2 | $321K | Buy |
38,687
+1,427
| +4% | +$11.8K | ﹤0.01% | 2623 |
|
|
2019
Q1 | $370K | Buy |
37,260
+15,125
| +68% | +$150K | ﹤0.01% | 2502 |
|
|
2018
Q4 | $169K | Buy |
+22,135
| New | +$169K | ﹤0.01% | 2730 |
|